TuHURA Biosciences, Inc.
Price Action
Technical Summary
CONSOLIDATINGTuHURA Biosciences, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is leading (RS Rating: 91), indicating clear outperformance against the broad market. Earnings growth of 13% provides fundamental context to the price action. Investors should exercise caution due to high volatility (135% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $2.28 | +0.40% | ABOVE |
| 50 SMA | $2.36 | -3.04% | BELOW |
| 100 SMA | $2.02 | +13.32% | ABOVE |
| 150 SMA | $1.69 | +35.34% | ABOVE |
| 200 SMA | $1.87 | +22.31% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is HURA in an uptrend right now?
HURA has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is HURA overbought or oversold?
HURA's RSI (14) is 46. The stock is in neutral territory, neither overbought nor oversold.
Is HURA outperforming the market?
HURA has a Relative Strength (RS) Rating of 91 out of 99. Yes, HURA is a market leader, outperforming 91% of all stocks over the past 12 months.
Where is HURA in its 52-week range?
HURA is trading at $2.29, which is 59% of its 52-week high ($3.90) and 54% above its 52-week low ($0.41).
How volatile is HURA?
HURA has a Beta of 3.42 and 52-week volatility of 135%. It's more volatile than the S&P 500 - expect bigger swings.